Clinical retrospective analysis of coagulation abnormalities caused by tigecycline
10.12173/j.issn.1005-0698.202407052
- VernacularTitle:替加环素致凝血功能异常的临床回顾分析
- Author:
Qiao LI
1
;
Min NI
;
Yuying YAN
;
Lingchen JIANG
;
Fuming SHEN
Author Information
1. 南京医科大学药学院(南京 211166)
- Keywords:
Tigecycline;
Coagulation abnormalities;
Coagulation indexes;
Thromboelastogram
- From:
Chinese Journal of Pharmacoepidemiology
2024;33(10):1099-1106
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the effect of tigecycline on coagulation function and to provide a reference for the clinical rational use of tigecycline.Methods The data of patients treated with tigecycline in Shanghai Tenth People's Hospital between June 2019 and December 2023 by retrospective analysis.Statistical analysis was performed by collecting data on patients'basic information,routine coagulation parameters and thromboelastogram(TEG)parameters before and after the use of tigecycline.Results Activated partial thromboplastin time,prothrombin time and thrombin time were prolonged and fibrinogen levels were decreased with the use of tigecycline in 41 patients,the differences were statistically significant(P＜0.05).There was no significant difference in levels of coagulation factor activation time,clot formation rate parameter,maximum angle of tangency,maximum amplitude of elastography and coagulation index after treatment with tigecycline(P＞0.05).Conclusion For patients with suspected coagulation abnormalities after tigecycline administration,a comprehensive assessment of coagulation should be made by combining routine coagulation indexes with TEG.
